Profound Medical Corp is experiencing a positive surge in its stock price, reflecting investor confidence.
Profound Medical Corp (PRN.TO) is rising today, gaining 3.31% to close at CA$9.98. This uptick comes despite a lack of recent news, indicating a potential shift in investor sentiment or market dynamics surrounding the company.
Investor takeaway: The increase in Profound Medical's stock price today suggests that investors are optimistic about the company's future prospects, even in the absence of specific news.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$351.02M
52W high
$12.40
52W low
$5.23
1W change
+1.26%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 159.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+159.1% Upside
Current Price
C$9.66
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
38.8%
Annualized
90-Day Vol
57.2%
Annualized
Trend (90d)
+21.9%
Annualized drift
90d Mean
C$10.44
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.91 | C$8.67 – C$11.34 |
| 60 trading days | C$10.18 | C$8.42 – C$12.30 |
| 90 trading days | C$10.44 | C$8.28 – C$13.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Profound Medical Corp's stock up 3.31% today
The market cap of Profound Medical Corp is CA$358 million, indicating a relatively small but potentially growing player in the medical technology sector.
Bull case
The rise in the stock price could mean that investors are gaining confidence in Profound Medical's innovative TULSA-PRO® technology. With major medical conferences coming up, this could boost the company's visibility and attract new investors.
Bear case
However, investors should be cautious. The company has a profit margin of -2.07%, and the lack of recent news might suggest that today’s gains are more about speculation than solid fundamentals.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
